Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Glycopeptides - ProtoKinetix

Drug Profile

Glycopeptides - ProtoKinetix

Alternative Names: AAGP™ molecules

Latest Information Update: 10 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Institut National des Sciences Appliquees de Rouen; ProtoKinetix
  • Developer Imaginative Research Associates; ProtoKinetix; ProtoKinetix - Imaginative Research Associates (JV); University of Alberta; University of British Columbia
  • Class Glycopeptides; Glycoproteins; Small molecules
  • Mechanism of Action Antioxidants; Free radical scavengers; Selectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Diabetes mellitus; Macular degeneration
  • No development reported Inflammation; Ocular inflammation; Skin disorders

Most Recent Events

  • 04 Sep 2018 ProtoKinetix plans clinical trials for Kidney disorders and Liver disorders
  • 10 Jan 2018 ProtoKinetix and University of British Columbia sign a research agreement to test the effect of glycopeptides on monoclonal antibody production and bone marrow recovery
  • 10 Jan 2018 ProtoKinetix plans studies for whole organ transplantation and Diabetes mellitus, Macular degeneration and Cardiac repair
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top